Navigation Links
Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
Date:8/19/2007

n asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. http://www.genaera.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. Such statements include, among others, statements regarding these preliminary results, clinical development plans and prospects for Genaera's programs including trodusquemine (MSI-1436), the IL-9 antibody program, LOMUCIN(TM), or squalamine. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to: Genaera's history of operating losses since inception and its need for additional funds to operate its business; the costs, delays and uncertainties inherent in scientific research, drug development, clinical trials and the regulatory approval process; the risk that clinical trials for Genaera's product candidates, including trodusquemine (MSI-1436), the IL-9 antibody program, LOMUCIN(TM), or squalamine may be delayed or may not be successful; the risk that Genaera may not obtain regulatory approval for its products, whether due to adequacy of the development program, the conduct of the clinical trials, changing regulatory requirements, different methods of evaluating and interpreting data, regulatory interpretations of clinical risk and benefit,
'/>"/>

SOURCE Genaera Corporation

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... BALTIMORE, Dec. 15 Champions Biotechnology, ... engaged in the development of advanced preclinical platforms ... of oncology drugs, today announced its financial results ... 2009. Full details of Company,s financial results ... www.championsbiotechnology.com . ,, Total revenues for the ...
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) ... received a written notice (the "Notice") executed by the ... of the Company, requesting that the Board of Directors ... for stockholder action by written consent relating to the ... director seat resulting from Ronald J. Kanterman,s departure (the ...
(Date:12/15/2009)... -- OrthoWorx, the newly formed industry, community and education ... in Kosciusko County, is working to connect the orthopedics ... and Cleveland via high-speed rail. ,, In a September ... Capital of the World -- An overview, analysis ... BioCrossroads, the statewide initiative to grow Indiana,s unique ...
Breaking Medicine Technology:Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Its Now or Never Deadline for Olympic Hopeful Skater With Secret Weapon 56470 1Its Now or Never Deadline for Olympic Hopeful Skater With Secret Weapon 56470 2Trubion Pharmaceuticals Inc to Present at the Morgan Stanley Global Healthcare Conference 13910 1Trubion Pharmaceuticals Inc to Present at the Morgan Stanley Global Healthcare Conference 13910 2Blood Test Narrows Down Need for Antibiotics 56463 1Blood Test Narrows Down Need for Antibiotics 56463 2Blood Test Narrows Down Need for Antibiotics 56463 3
(Date:12/15/2009)... for lying about taxes in the healthcare bill ... earned a place under the "Naughty" column on Americans for ... being caught telling a brazen lie on the floor of ... would not raise taxes. ,, Speaking on the U.S. ... " I have also heard it argued ...
(Date:12/15/2009)... Dec. 15 Our Lady of Lourdes Health ... Jersey hospitals, has agreed to pay the United States ... Medicare, the Justice Department announced today. The two hospitals ... Camden, N.J., and Lourdes Medical Center of Burlington County ... defendant in a suit brought by a whistleblower, Tony ...
(Date:12/15/2009)... in area where all couples of reproductive age were ... News) -- The number of children born with cystic ... be CF mutation carriers increases, a new study finds. ... area of northeast Italy for many years. Since the ... in the number of infants born with CF. , ...
(Date:12/15/2009)... would have really been in trouble, expert says , , ... the pandemic H1N1 swine flu has revealed serious flaws ... emergencies, a new report says. , The report, prepared ... Wood Johnson Foundation, also finds the dire economy has ... 2009 H1N1 outbreak is the latest in a series ...
(Date:12/15/2009)... sobering statistics concerning the parallel rise in diabetes and obesity rates ... of combating this trend afflicting their workforce. , ... ... climbing across America due in large part to the alarming parallel ... has stated that the rate of diabetes could be cut in ...
Breaking Medicine News(10 mins):Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3
... today issued an urgent appeal for contributions for disaster relief to help ... ... MD (PRWEB) September 17, 2008 -- The American Kidney Fund today issued ... who have been affected by Hurricane Ike. , , , , ,The ...
... Panelist ... Sept. 16 Stop Falls Now! That is not just,a worthwhile ... Meeting and Exposition, but is now a reality. For the first ... this show., Beyond slogans or theory, LTC providers will be ...
... The National,Autism Association announced today that ... recipients of Project Lifesaver funding through the,organization,s ... the rise in,wandering-related deaths among children with ... tracking program established to,quickly locate and rescue ...
... of brain size, improved motor functioning, study finds ... experimental compound called HDACi 4b reversed Huntington,s disease ... disease, say researchers at the Scripps Research Institute ... neurological disease that affects people,s movement and thinking ...
... Launched to Lobby for Improved Nurse Staffing in Hospitals, ... his support for state legislation that would increase the,number ... at a press,conference called by the RN2RN Network, a ... take action to protect patients., "Given estimates that ...
... Particle Sciences, Inc.,announces the issuing of its ... density of sintered metal products. The technology allows,for ... that decreases needed,injection forces, decreases lubricant requirements and ... a proprietary coating,applied to the powders prior to ...
Other Medicine News:Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 3Health News:Samarion(SM) to Demonstrate Unprecedented Fall Prevention Component of Enterprise Quality Improvement System for LTC Facilities at the AAHSA 2008 Annual Meeting & Exposition 2Health News:National Autism Association's 'FOUND' Provides Funds to Union County Sheriff's Office for Project Lifesaver Equipment 2Health News:Compound Reverses Huntington's Symptoms in Mice 2Health News:Lt. Gov. Quinn Backs Patient Care Reforms 2Health News:Lt. Gov. Quinn Backs Patient Care Reforms 3Health News:Particle Sciences Develops Methods for Increasing Quality of Sintered Metal Products and for Coating Surfaces with Metal Oxide Films 2
... The GenoSensor System includes genomic ... software, and reagents. By utilizing ... (CGH) technology for multi-target assessment, ... analyze multiple genomic targets in ...
The ABI PRISM 3100 Genetic Analyzer, a multi-color fluorescence-based DNA analysis system with 16 capillaries operating in parallel, offers high-quality data and efficient sample processing for the b...
... CELL-DYN 1800 is the latest 3-part differential ... since the founding of the CELL-DYN line. ... data management capabilities, the CELL-DYN 1800 meets ... CELL-DYN 1800 is smaller than its predecessors ...
... The QC Manager Point-of-Care Data Management System ... Blood Glucose Testing System and the Precision ... simple, automated way to collect, analyze, and ... format. It provides an essential laboratory tool ...
Medicine Products: